Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes

FRIDAY, Dec. 16, 2022 (HealthDay News) -- There is a higher risk for adverse dental outcomes associated with sublingual buprenorphine/naloxone compared with transdermal buprenorphine or oral naltrexone, according to a research letter published in the Dec. 13 issue of the Journal of the American Medical Association.
Mahyar Etminan, Pharm.D., from the University of British Columbia in Vancouver, Canada, and colleagues used the PharMetrics database to examine the association between sublingual buprenorphine/naloxone and dental adverse events. The analysis included 21,404 new users of sublingual buprenorphine/naloxone, 5,385 users of transdermal buprenorphine, and 6,616 users of oral naltrexone.
The researchers found that the incidence of any dental adverse event was 21.6 per 1,000 person-years with sublingual buprenorphine/naloxone, 12.2 per 1,000 person-years with transdermal buprenorphine, and 10.9 per 1,000 person-years with oral naltrexone. The risk for dental adverse events was higher for sublingual buprenorphine/naloxone versus both transdermal buprenorphine (adjusted hazard ratio [aHR], 1.42) and oral naltrexone (aHR, 1.67). Similarly, the incidence of dental caries or tooth loss was 8.2 per 1,000 person-years with sublingual buprenorphine/naloxone, 3.5 per 1,000 person-years with transdermal buprenorphine, and 3.8 per 1,000 person-years with oral naltrexone. A higher risk for dental caries or tooth loss was seen for sublingual buprenorphine/naloxone versus both transdermal buprenorphine (aHR, 1.57) and oral naltrexone (aHR, 1.71).
"Clinicians might consider drugs other than sublingual buprenorphine/naloxone in patients with previous dental problems," the authors write. "These patients might also benefit from regular oral health examinations by their dentist."
Abstract/Full Text (subscription or payment may be required)
Related Posts
La intensa ola de calor es un peligro para las personas con demencia
MARTES, 11 de julio de 2023 (HealthDay News) -- A medida que un calor extremo...
Resolved to Lose Weight in 2023? Experts Compare Popular Diets
TUESDAY, Jan. 3, 2023 (HealthDay News) -- Losing weight is one of the most...
Full Resolution of Symptoms Seen in Most Children With Lyme Disease
MONDAY, May 1, 2023 (HealthDay News) -- Most children with Lyme disease...
Walgreens no venderá pastillas para abortar en 20 estados republicanos
LUNES, 6 de marzo de 2023 (HealthDay News) -- Tras recibir una carta de...
